Production of neutralizing human monoclonal antibody directed to tetanus toxin in CHO cell

被引:11
作者
Chin, J
Sohn, Y
Lee, SH
Park, YI
Choi, MJ [1 ]
机构
[1] Korea Inst Sci & Technol, Ctr Bioanal, Seoul 130650, South Korea
[2] Korea Inst Sci & Technol, Biotransformat Res Ctr, Seoul 130650, South Korea
[3] Korea Univ, Grad Sch Biotechnol, Mol Biol Lab, Seoul 136701, South Korea
[4] Korea Food & Drug Adm, Ctr Biol Evaluat, Seoul 122704, South Korea
关键词
toxin-neutralization; anti-tetanus monoclonal antibodies; protection against tetanus; chinese hamster ovary cells; recombinant human IgG;
D O I
10.1016/S1045-1056(02)00092-1
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
By the fusion of lymphocytes from hyperimmunized people with heteromyeloma cells, 600 human hybridoma cell lines were generated. Even though seven cell lines produced antibodies against tetanus toxoid, only two antibodies from hybrid CH8 and CH5 only neutralized the tetanus toxin and completely protected the mice that had been challenged with the toxin even at the level of 90 mean lethal dose. The cDNA of light (L) chain and heavy (H) chain variable region was isolated,and then inserted into expression vectors containing human IgG constant regions. After transfection of the recombinant human IgG gene into Chinese Hamster Ovary (CHO) cells, transformants secreting the complete human antibody were selected. The recombinant human antibodies produced from CHO cells possessed neutralizing activity against tetanus toxin just like the original human antibodies produced from human hybridoma cell lines. Western blot analysis showed that rCH8 and rCH5 antibodies recognized the H chain of tetanus toxin and did not bind to its L chain. The neutralizing test showed that HmAb rCH5 had 4.55 IU and HmAb rCH8 had 1.09 IU/100 mug of IgG, respectively. Mixing of the two HmAbs resulted in synergistic effects. On a weight basis (IU/100 mug IgG), the highest potency values were obtained when the two HmAbs were combined in equal quantity. The neutralizing activity of rCH8 and rCH5 mixture was 6.94 IU/ 100 mug IgG. (C) 2003 The International Association for Biologicals. Published by Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:45 / 53
页数:9
相关论文
共 13 条
[1]   A SINGLE HUMAN MONOCLONAL-ANTIBODY THAT CONFERS TOTAL PROTECTION FROM TETANUS [J].
ARUNACHALAM, B ;
GHOSH, S ;
TALWAR, GP ;
RAGHUPATHY, R .
HYBRIDOMA, 1992, 11 (02) :165-179
[2]   Inhibition of tetanus toxin fragment C binding to ganglioside GT1b by monoclonal antibodies recognizing different epitopes [J].
Fitzsimmons, SP ;
Clark, KC ;
Wilkerson, R ;
Shapiro, MA .
VACCINE, 2000, 19 (01) :114-121
[3]   MEASUREMENTS OF THE TRUE AFFINITY CONSTANT IN SOLUTION OF ANTIGEN-ANTIBODY COMPLEXES BY ENZYME-LINKED IMMUNOSORBENT-ASSAY [J].
FRIGUET, B ;
CHAFFOTTE, AF ;
DJAVADIOHANIANCE, L ;
GOLDBERG, ME .
JOURNAL OF IMMUNOLOGICAL METHODS, 1985, 77 (02) :305-319
[4]  
JOHN S, 1989, HYBRIDOMA, V8, P529
[5]  
Kabat E.A., 1987, SEQUENCES PROTEINS I, DOI DOI 10.1016/0003-2697(84)90805-4
[6]   ESTABLISHMENT OF STABLE MOUSE HUMAN-HUMAN HYBRID CELL-LINES PRODUCING LARGE AMOUNTS OF ANTITETANUS HUMAN MONOCLONAL-ANTIBODIES WITH HIGH NEUTRALIZING ACTIVITY [J].
KAMEI, M ;
HASHIZUME, S ;
SUGIMOTO, N ;
OZUTSUMI, K ;
MATSUDA, M .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1990, 6 (04) :386-397
[7]  
Kolbe DR, 1999, FEMS IMMUNOL MED MIC, V24, P313, DOI 10.1111/j.1574-695X.1999.tb01299.x
[8]  
LANG AB, 1993, J IMMUNOL, V151, P466
[9]   RAPID CLONING OF REARRANGED IMMUNOGLOBULIN GENES FROM HUMAN HYBRIDOMA CELLS USING MIXED PRIMERS AND THE POLYMERASE CHAIN-REACTION [J].
LARRICK, JW ;
DANIELSSON, L ;
BRENNER, CA ;
ABRAHAMSON, M ;
FRY, KE ;
BORREBAECK, CAK .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 160 (03) :1250-1256
[10]   CHARACTERISTICS OF TOXIN-NEUTRALIZATION BY ANTITETANUS HUMAN MONOCLONAL-ANTIBODIES DIRECTED AGAINST THE 3 FUNCTIONAL DOMAINS [A], [B] AND [C] OF THE TETANUS TOXIN MOLECULE AND A RELIABLE METHOD FOR EVALUATING THE PROTECTIVE EFFECTS OF MONOCLONAL-ANTIBODIES [J].
MATSUDA, M ;
KAMEI, M ;
SUGIMOTO, N ;
MA, Y ;
HASHIZUME, S .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 1992, 8 (01) :1-8